PMCID
string | Title
string | Sentences
string |
|---|---|---|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
We found that MIF/CXCR4 LR was the most common crosstalk between tumor cells and macrophages in G01 and G02 ( Figures 4 – 6 ).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Interactions numbers and interaction weights of cell-to-cell. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Numbers of interactions in G01. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Weights of interactions in G01. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Numbers of interactions in G02. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Weights of interactions in G2.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
G01, high risk GIST; G02, very low risk GIST.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Outgoing and incoming signaling patterns of Cell-Chat in G01.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Outgoing and incoming signaling patterns of Cell-Chat in G02.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
MIF/CXCR4 axis was the most crosstalk ligand-receptor between tumor cells and macrophages in G01 (A) and G02 (B).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
LR interactions between tumor cells and other cells play an important role in tumor proliferation, metastasis, and progression.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Thus, the MIF/CXCR4 signaling axis between tumor cells and macrophages was selected for further investigation.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
In this study, 80 patients were included for immunohistochemistry.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Their clinicopathological characteristics are presented in Table 3 .
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
In these patients, 56 tumors were located in the stomach and 24 tumors were located in the intestine.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Fourteen patients were classified as the very-low-risk group (LG), 31 patients were classified as the intermediate-risk group (MG), and 35 patients were classified as the high-risk group (HG).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Clinicopathological characteristics of 80 patients for immunohistochemistry.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Immunohistochemistry and immunofluorescence were performed ( Figures 7 , 8 ).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Among the three groups, CD8+ T cells were the most abundant in the LG (LG vs. MG vs. HG: 0.35 ± 0.15 vs. 0.27 ± 0.10 vs. 0.09 ± 0.02, P = 0.003), whereas CD68 macrophages were the most abundant in the HG (LG vs. MG vs. HG: 0.38 ± 0.09 vs. 0.64 ± 0.17 vs. 0.98 ± 0.19, P = 0.03) ( Figure 9A ).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The expression of CD206 in the HG was the highest among the three groups (LG vs. MG vs. HG: 0.04 ± 0.01 vs. 0.07 ± 0.02 vs. 0.15 ± 0.03, P < 0.001).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Such a phenomenon was also found in MIF expression and CXCR4 expression.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Namely, among the three groups, the expression levels of MIF and CXCR4 were the highest in the HG (LG vs. MG vs. HG: 0.43 ± 0.24 vs. 0.90 ± 0.68 vs. 1.64 ± 0.53, P < 0.001; LG vs. MG vs. HG: 0.009 ± 0.003 vs. 0.70 ± 0.02 vs. 0.12 ± 0.03, P < 0.001) ( Figure 9B ).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Summarily, CD8, CD68, CD206, MIF, and CXCR4 expression are related with tumor progression.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Immunohistochemical characterization of CD8, CD68, MIF, CD206 and CXCR4 in GIST samples. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Immunofluorescence showed that co-expression of CD68 and CXCR4 in GIST sample. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Immunofluorescence showed that MIF expression is present both inside and outside GIST cells. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
(A) There were differences in CD8+T cell infiltration among different groups (0.35 ± 0.15 vs 0.27 ± 0.10 vs 0.09 ± 0.02, P=0.003); (B) There were differences in the infiltration of CD68+macrophage cells among different groups (0.38 ± 0.09 vs 0.64 ± 0.17 vs 0.98 ± 0.19, P=0.03). (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
(A) As the risk increases, the expression of CXCR4 gradually increases, and the difference is statistically significant (0.43 ± 0.24 vs 0.90 ± 0.68 vs 1.64 ± 0.53, P<0.001); (B) As the risk increases, the expression of MIF gradually increases, and the difference is statistically significant (0.009 ± 0.003 vs 0.70 ± 0.02 vs 0.12 ± 0.03, P<0.001); (C) As the risk increases, the expression of CD206 gradually increases, and the difference is statistically significant (0.04 ± 0.01 vs 0.07 ± 0.0.02 vs 0.15 ± 0.03, P<0.001); The statistical method is non-parametric test, n=80, *P<0.05; **P<0.01.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Previous data have shown high expression of MIF in GIST tissues.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
To determine whether GIST-882 cell line secretes MIF, we performed an ELISA trial.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
As expected, GIST-882 cell line secreted MIF, and MIF gradually increased with time.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
When we administered ISO-1 (MIF inhibitor) to the GIST-882 cell line, secretion of MIF decreased ( Figure 10 ). (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
GIST882 cells could express CD117; (B) GIST-882 cells could secrete MIF and MIF increased gradually along with the time.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
ISO-1 could inhibit the secretion of MIF.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
To explore the effect of GIST-882 cell line on macrophages in vitro, the cell supernatant was collected as conditioned medium (CM), cultured to M0 macrophages.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Compared with the control group, M2 macrophages increased in the GIST882 CM group.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
However, when we administered ISO-1, M2 macrophages decreased.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The difference between the two groups suggested that MIF was a factor to modulate M2 polarization of macrophages.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Interestingly, when we administered WZ811 (CXCR4 antagonist), M2 macrophages also decreased ( Figures 11A, B ). (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
(A) GIST882 CM group; (B) GIST882 CM+ISO-1 group; Ctrl group vs GIST882 CM group, 1.6% vs 27.3%, P=0.000; GIST882 CM group vs GIST882 CM+ISO-1 group,27.3% vs 11.9%, P=0.006; ISO-1:MIF inhibitor; The statistical method is chi square test, **:P<0.01. (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
(A) GIST882CM group; (B) GIST882CM+WZ811 group.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Ctrl vs GIST882CM group:1.6% vs 24.8%, P=0.000; GIST882CM group vs GIST882CM+WZ811group:24.8% vs 9.3%, P=0.004; WZ811:CXCR4 antagonists; The statistical method is chi square test, **:P<0.01.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
To further confirm the polarization of M2 macrophages, IL-10 mRNA and Arginase-1 mRNA were detected.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The expression levels of IL-10 mRNA and Arginase-1 mRNA were in concordance with the results of flow cytometry, and were the highest in the GIST882 CM group ( Figure 12 ). (
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Ctrl vs GIST882CM vs GIST882CM +ISO-1 vs GIST882CM +WZ811:1.17 ± 0.43 vs 5.40 ± 1.21 vs 1.17 ± 0.23 vs 1.57 ± 0.57; (B) Ctrl vs GIST882CM vs GIST882CM +ISO-1 vs GIST882CM +WZ811:1.05 ± 0.18 vs 1.83 ± 0.18 vs 0.84 ± 0.30 vs 0.80 ± 0.17; ISO-1: MIF inhibitor; WZ811: CXCR4 antagonists; The statistical method is T-test, mean ± SEM, n=3, *P<0.05; **P<0.01.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The incidence of GIST is 1.1 per 100,000, and accounts for 80% of all gastrointestinal sarcomas (22, 23).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The most common sites for GIST are the stomach (60%) and the small intestine (30%) (2, 24).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Given that mutations in KIT or PDGFRA have been identified, the treatment strategy for GIST is targeted therapy.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Imatinib, sunitinib, regorafenib, and ripretinib have been approved for the treatment of GIST.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Imatinib, the first-line system therapy, achieves an excellent disease control in 80% of patients (25).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
However, drug resistance is the most challenging clinical problem.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
As the new era of immunotherapy has arrived, the microenvironment of GIST and the roles of infiltrating cells in tumor surveillance and tumor progression should be clarified.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
CD3 T cells and macrophages have been found as the most abundant tumor-infiltrating immune cells in GIST (11, 12).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Our results revealed that CD8 T cells and macrophages were the most abundant tumor-infiltrating immune cells.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
We also analyzed the differences among LG, MG, and HG.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The results showed that macrophages were increased and CD8 T cells were exhausted with tumor progression, which is similar to other studies (11, 18).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
High infiltration of macrophages predicts poor prognosis in multiple types of tumors and is considered the reason of suppressed antitumor inflammatory setting (26–28).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
PD-1 expression by tumor-associated macrophages has been linked to inhibition of phagocytosis and immunity (29).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The M1/M2 polarization states of macrophages play an important role in tumor progression (30).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The inflammatory M1 state and protumor M2 state originate from different environmental stimuli (31).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
However, PD-1 expression has been found in M2-state tumor-associated macrophages (29).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
This discovery could explain the promotion of tumor progression by M2 macrophages.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
To clarify the polarization of macrophages in GIST, CD206 expression was examined.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
We showed that CD206 expression was the highest in the HG.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
However, the reason for the increase in tumor-infiltrating M2 macrophages in the high-risk GIST was not clear.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
So, we performed a CellChat analysis to clarify the crosstalk types between tumor cells and macrophages based on single-cell RNA sequencing data (32).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Through CellChat, we quantitatively inferred and analyzed intercellular communication networks.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The CellChat results showed that the MIF/CXCR4 axis was the main crosstalk type between tumor cells and macrophages.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
High expression of MIF has been found in many tumor tissues, such as breast cancer, lung cancer, and melanoma (33–35).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
It has also been revealed that high expression of MIF is closely related to tumor progression and metastasis (36).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
MIF could act on corresponding cells in autocrine or paracrine manner, resulting in changes in physiological functions.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Currently, four receptors for MIF have been discovered, namely CD74, CXCR2, CXCR4, and CXCR7 (37–40).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The MIF/CXCR4 axis has been found to contribute to cell survival, drug resistance, and tumor metastasis in multiple types of tumors (41–43).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
In ELISA trial, we found that GIST882 cells were able to secrete MIF, and immunohistochemical expression of MIF and CXCR4 was related to the recurrence risk.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
These results suggest that the MIF/CXCR4 axis could play a key role in GIST progression.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
In vitro, we found that the MIF/CXCR4 axis contributed to M2 polarization of macrophages.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The expression levels of MIF and CXCR4 have been identified as adverse prognostic factors in multiple types of tumors (43–45).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The MIF/CXCR4 axis could contribute to drug resistance in tumor invasion and metastasis (41, 43).
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
However, the mechanism of the MIF/CXCR4 axis in this process is unclear.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
Our results provide an idea to explain this phenomenon and stimulate further research.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
In conclusion, macrophages are the most abundant infiltrating cells in GIST.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
The MIF/CXCR4 axis is the most ligand–receptor interaction between macrophages and tumor cells.
|
PMC11502962
|
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
|
GIST cells can regulate macrophage M2 polarization through the MIF/CXCR4 axis to form an immunosuppressive microenvironment.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
Phosphodiesterase 3A (PDE3A) is an emerging therapy target in various cancers with high expression, as in the majority of gastrointestinal stromal tumors (GISTs).
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
However, its association with clinicopathological factors and patient survival in GISTs remains unexplored.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
We investigated PDE3A expression using a novel mouse monoclonal antibody and immunohistochemistry in two GIST patient series consisting of 173 formalin-fixed, paraffin-embedded tissue samples on tissue microarrays.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
In addition, we analyzed the association between PDE3A staining intensity and clinicopathological variables and patient survival.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
We also assessed PDE3A mRNA expression using qPCR in a subset of the samples.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
We found that all GISTs expressed PDE3A.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
The staining pattern was weak in 6.3%, intermediate in 35.8%, and strong in 57.8% of tumors.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
Weak PDE3A expression was associated with a lower median mitotic count (1/50 HPF vs. 4/50 HPF vs. 5/50 HPF; p = 0.007) and higher incidence of metastases at diagnosis (28% vs. 8% vs. 3.3%; p = 0.040) than in tumors with intermediate or strong expression, respectively.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
PDE3A and CD117 staining intensities correlated positively (p < 0.001), but PDE3A expression showed no association with sex, age, tumor size, location, risk stratification, mutation profile, Schlafen 12 expression, or metastasis-free or overall survival.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
We conclude that PDE3A expression can be reliably assessed in archived tumor material using immunohistochemistry.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
GISTs, with their consistently high PDE3A expression, are a promising target for PDE3A-targeted therapies.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
This method may also aid in stratifying patients in cancers where PDE3A expression is less common.
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
Gastrointestinal stromal tumor (GIST) is the most common gastrointestinal soft-tissue sarcoma with an annual incidence of 10 to 20 persons per million persons .
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
GIST is characterized by mutually exclusive gain-of-function mutations in KIT and platelet-derived growth factor receptor alpha (PDGFRA) oncogenes in ~ 85% of cases .
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
These mutations in receptor tyrosine kinase-encoding genes lead to ligand-independent constitutive activation of the kinases, driving uncontrolled tumor cell proliferation and survival .
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
In addition, the mutated receptors serve as key therapeutic targets for tyrosine kinase inhibitors such as imatinib, sunitinib, regorafenib, ripretinib, and avapritinib .
|
PMC12647229
|
Phosphodiesterase 3 A expression in gastrointestinal stromal tumors
|
However, the specific mutation type has a marked impact on therapy sensitivity of GISTs, and secondary resistance to therapies frequently evolves during treatment .
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.